01504nas a2200253   4500000000100000008004100001260003700042653005700079653002400136653001300160100001500173700001300188700001300201700001400214700001200228700001600240700002100256245009600277856009900373300001300472490000700485520074400492022001401236       2020                            d  bPublic Library of Science (PLoS)10aPublic Health, Environmental and Occupational Health10aInfectious Diseases10aCovid-191 aChaumont C1 aKamara K1 aBaring E1 aPalacio K1 aPower A1 aLancaster W1 aVan Weyenbergh J00aThe SARS-CoV-2 crisis and its impact on neglected tropical diseases: Threat or opportunity?  uhttps://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0008680&type=printable  ae00086800 v143 aIntroduction
The current global priority is to protect people from attaining the COVID-19 infection and to attend to those infected, resulting in the disruption of other activities of the health sector, such as neglected tropical disease (NTD) control and elimination programs, which, across the globe, have postponed mass drug administration (MDA) campaigns. The impact of this disruption, combined with that of the pandemic, will ripple for years to come. This commentary reflects on how the current crisis modifies the future of the NTD sector focused on the five diseases treated through preventative chemotherapy (often called PC-NTDs): soil-transmitted helminths, schistosomiasis, lymphatic filariasis, onchocerciasis, and trachoma.  a1935-2735